Jump to navigation
A six-month-long study found that hazardous alcohol use increased monthly for those under stay-at-home orders, especially among younger adults, males and those who had lost their jobs.
The test uses a smartphone microscope to analyze saliva samples and deliver results in about 10 minutes.
UArizona Health Sciences immunobiologists have created a five-module chimeric antigen receptor T cell that is showing early potential to fight Type 1 diabetes.
A study led by Dr. Julie Bauman will be expanded to further investigate the safety and effectiveness of a personalized cancer vaccine.
UArizona researchers have developed a method of using ketamine in the treatment of Parkinson’s disease. The discovery has been licensed to Pharmather Inc. for development and commercialization.
Dr. Sairam Parthasarathy is one of 11 principal investigators for the National Institutes of Health Community Engagement Alliance Against COVID-19 Disparities.
Researchers have developed a rapid, simplified method for producing radio-labeling compounds used for PET scans.
UArizona researchers developed one of the most accurate COVID-19 antibody tests available and now have shown antibodies persist for months after infection, providing long-term immunity.
Antibodies normally fight viruses, but in the case of flaviviruses, they can make infections worse. UArizona Health Sciences immunologists took a closer look at antibody production to figure out why, which could lead to new methods of developing vaccines for flaviviruses.
Researchers found that SARS-CoV-2 can relieve pain, which may explain why nearly half of the people who get COVID-19 experience few or no symptoms.
